Exact Mass: 539.1450566000001
Exact Mass Matches: 539.1450566000001
Found 113 metabolites which its exact mass value is equals to given mass value 539.1450566000001
,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
Mezlocillin
Mezlocillin is only found in individuals that have used or taken this drug. It is a semisynthetic ampicillin-derived acylureido penicillin. It has been proposed for infections with certain anaerobes and may be useful in inner ear, bile, and CNS infections. [PubChem]By binding to specific penicillin-binding proteins (PBPs) located inside the bacterial cell wall, mezlocillin inhibits the third and last stage of bacterial cell wall synthesis. Cell lysis is then mediated by bacterial cell wall autolytic enzymes such as autolysins; it is possible that mezlocillin interferes with an autolysin inhibitor. J - Antiinfectives for systemic use > J01 - Antibacterials for systemic use > J01C - Beta-lactam antibacterials, penicillins > J01CA - Penicillins with extended spectrum D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D047090 - beta-Lactams D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D010406 - Penicillins D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D007769 - Lactams C254 - Anti-Infective Agent > C258 - Antibiotic > C260 - Beta-Lactam Antibiotic
Pipracil
C23H26N5NaO7S (539.1450566000001)
D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D047090 - beta-Lactams D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D010406 - Penicillins D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D007769 - Lactams C254 - Anti-Infective Agent > C258 - Antibiotic > C260 - Beta-Lactam Antibiotic
Phytochelatin 2
C18H29N5O10S2 (539.1355774000001)
A phytochelatin that is a pentapeptide consisting of 2 units of gamma-Glu-Cys, with a glycyl unit at the C-terminus.
Pulcherosine
Pulcherosine is found in herbs and spices. Pulcherosine is found in the primary cell walls of tomato cell cultures. Found in the primary cell walls of tomato cell cultures
Encorafenib
L - Antineoplastic and immunomodulating agents > L01 - Antineoplastic agents > L01E - Protein kinase inhibitors > L01EC - B-raf serine-threonine kinase (braf) inhibitors C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor > C61074 - Serine/Threonine Kinase Inhibitor C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C2336 - Raf Kinase Inhibitor C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor Encorafenib (LGX818) is a highly potent BRAF inhibitor with selective anti-proliferative and apoptotic activity in cells expressing BRAFV600E (EC50=4 nM).
N-[4-[(4-Ethylamino-3-methylphenyl)(2-sulfonato-4-sodiosulfophenyl)methylene]-2-methyl-2,5-cyclohexadien-1-ylidene]ethanaminium
C25H28N2NaO6S2+ (539.1286408000001)
(gamma-Glu-Cys)2-Gly|Cadystin (gammaEC)2G|gammaGlu-Cys-gammaGlu-Cys-Gly|H-(gamma-Glu-Cys)2-Gly-OH|H-2-Gly-OH|H-gamma-L-Glu-L-Cys-gamma-L-Glu-L-Cys-Gly-OH (cadystin B <2>)|PC2
C18H29N5O10S2 (539.1355774000001)
Asn Tyr Glu Asp
Nafamostat mesylate
D007155 - Immunologic Factors > D007166 - Immunosuppressive Agents > D051056 - Complement Inactivating Agents D004791 - Enzyme Inhibitors > D011480 - Protease Inhibitors > D015842 - Serine Proteinase Inhibitors C78272 - Agent Affecting Nervous System > C241 - Analgesic Agent > C2198 - Nonnarcotic Analgesic COVID info from clinicaltrial, clinicaltrials, clinical trial, clinical trials D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents D002491 - Central Nervous System Agents > D000700 - Analgesics D006401 - Hematologic Agents > D000925 - Anticoagulants C471 - Enzyme Inhibitor > C783 - Protease Inhibitor D000893 - Anti-Inflammatory Agents D018501 - Antirheumatic Agents Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS
Cys Cys Glu Trp
Cys Cys Trp Glu
Cys Glu Cys Trp
Cys Glu Trp Cys
Cys Met Thr Trp
C23H33N5O6S2 (539.1872158000001)
Cys Met Trp Thr
C23H33N5O6S2 (539.1872158000001)
Cys Thr Met Trp
C23H33N5O6S2 (539.1872158000001)
Cys Thr Trp Met
C23H33N5O6S2 (539.1872158000001)
Cys Trp Cys Glu
Cys Trp Glu Cys
Cys Trp Met Thr
C23H33N5O6S2 (539.1872158000001)
Cys Trp Thr Met
C23H33N5O6S2 (539.1872158000001)
Asp Asp Gln Tyr
Asp Asp Tyr Gln
Asp Glu Asn Tyr
Asp Glu Tyr Asn
Asp Asn Glu Tyr
Asp Asn Tyr Glu
Asp Gln Asp Tyr
Asp Gln Tyr Asp
Asp Tyr Asp Gln
Asp Tyr Glu Asn
Asp Tyr Asn Glu
Asp Tyr Gln Asp
Glu Cys Cys Trp
Glu Cys Trp Cys
Glu Asp Asn Tyr
Glu Asp Tyr Asn
Glu Asn Asp Tyr
Glu Asn Tyr Asp
Glu Trp Cys Cys
Glu Tyr Asp Asn
Glu Tyr Asn Asp
Met Cys Thr Trp
C23H33N5O6S2 (539.1872158000001)
Met Cys Trp Thr
C23H33N5O6S2 (539.1872158000001)
Met Met Met Gln
Met Met Gln Met
Met Gln Met Met
Met Thr Cys Trp
C23H33N5O6S2 (539.1872158000001)
Met Thr Trp Cys
C23H33N5O6S2 (539.1872158000001)
Met Trp Cys Thr
C23H33N5O6S2 (539.1872158000001)
Met Trp Thr Cys
C23H33N5O6S2 (539.1872158000001)
Asn Asp Glu Tyr
Asn Asp Tyr Glu
Asn Glu Asp Tyr
Asn Glu Tyr Asp
Asn Tyr Asp Glu
Gln Asp Asp Tyr
Gln Asp Tyr Asp
Gln Met Met Met
Gln Tyr Asp Asp
Thr Cys Met Trp
C23H33N5O6S2 (539.1872158000001)
Thr Cys Trp Met
C23H33N5O6S2 (539.1872158000001)
Thr Met Cys Trp
C23H33N5O6S2 (539.1872158000001)
Thr Met Trp Cys
C23H33N5O6S2 (539.1872158000001)
Thr Trp Cys Met
C23H33N5O6S2 (539.1872158000001)
Thr Trp Met Cys
C23H33N5O6S2 (539.1872158000001)
Trp Cys Cys Glu
Trp Cys Glu Cys
Trp Cys Met Thr
C23H33N5O6S2 (539.1872158000001)
Trp Cys Thr Met
C23H33N5O6S2 (539.1872158000001)
Trp Glu Cys Cys
Trp Met Cys Thr
C23H33N5O6S2 (539.1872158000001)
Trp Met Thr Cys
C23H33N5O6S2 (539.1872158000001)
Trp Thr Cys Met
C23H33N5O6S2 (539.1872158000001)
Trp Thr Met Cys
C23H33N5O6S2 (539.1872158000001)
Tyr Asp Asp Gln
Tyr Asp Glu Asn
Tyr Asp Asn Glu
Tyr Asp Gln Asp
Tyr Glu Asp Asn
Tyr Glu Asn Asp
Tyr Asn Asp Glu
Tyr Asn Glu Asp
Tyr Gln Asp Asp
Pulcherosine
4-[(2,4-Dimethoxyphenyl)(Fmoc-amino)methyl]phenoxyacetic Acid
choline magnesium trisalicylate
C26H29MgNO10 (539.1641874000001)
D000893 - Anti-Inflammatory Agents > D000894 - Anti-Inflammatory Agents, Non-Steroidal > D012459 - Salicylates C78272 - Agent Affecting Nervous System > C241 - Analgesic Agent > C2198 - Nonnarcotic Analgesic D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents D002491 - Central Nervous System Agents > D000700 - Analgesics D018501 - Antirheumatic Agents
5-[2-[3-(4-Fluorophenyl)-5-thiophen-2-yl-3,4-dihydropyrazol-2-yl]-2-oxoethoxy]-2-(phenylmethyl)-3,4-dihydroisoquinolin-1-one
Encorafenib
L - Antineoplastic and immunomodulating agents > L01 - Antineoplastic agents > L01E - Protein kinase inhibitors > L01EC - B-raf serine-threonine kinase (braf) inhibitors C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor > C61074 - Serine/Threonine Kinase Inhibitor C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C2336 - Raf Kinase Inhibitor C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor Encorafenib (LGX818) is a highly potent BRAF inhibitor with selective anti-proliferative and apoptotic activity in cells expressing BRAFV600E (EC50=4 nM).
N-[5,6-bis[(2,3-dihydroxybenzoyl)amino]hexyl]-2,3-dihydroxybenzamide
N-[(2S,4aR,12aR)-5-methyl-6-oxo-2-[2-oxo-2-(2,2,2-trifluoroethylamino)ethyl]-2,3,4,4a,12,12a-hexahydropyrano[2,3-c][1,5]benzoxazocin-8-yl]-2-chlorobenzamide
N-[(2S,4aS,12aR)-5-methyl-6-oxo-2-[2-oxo-2-(2,2,2-trifluoroethylamino)ethyl]-2,3,4,4a,12,12a-hexahydropyrano[2,3-c][1,5]benzoxazocin-8-yl]-2-chlorobenzamide
N-[(2R,4aR,12aS)-5-methyl-6-oxo-2-[2-oxo-2-(2,2,2-trifluoroethylamino)ethyl]-2,3,4,4a,12,12a-hexahydropyrano[2,3-c][1,5]benzoxazocin-8-yl]-2-chlorobenzamide
N-[(2R,4aS,12aR)-5-methyl-6-oxo-2-[2-oxo-2-(2,2,2-trifluoroethylamino)ethyl]-2,3,4,4a,12,12a-hexahydropyrano[2,3-c][1,5]benzoxazocin-8-yl]-2-chlorobenzamide
N-[(2S,4aR,12aS)-5-methyl-6-oxo-2-[2-oxo-2-(2,2,2-trifluoroethylamino)ethyl]-2,3,4,4a,12,12a-hexahydropyrano[2,3-c][1,5]benzoxazocin-8-yl]-2-chlorobenzamide
N-[(2R,4aR,12aR)-5-methyl-6-oxo-2-[2-oxo-2-(2,2,2-trifluoroethylamino)ethyl]-2,3,4,4a,12,12a-hexahydropyrano[2,3-c][1,5]benzoxazocin-8-yl]-2-chlorobenzamide
N-[(2S,4aS,12aS)-5-methyl-6-oxo-2-[2-oxo-2-(2,2,2-trifluoroethylamino)ethyl]-2,3,4,4a,12,12a-hexahydropyrano[2,3-c][1,5]benzoxazocin-8-yl]-2-chlorobenzamide
Mezlocillin
J - Antiinfectives for systemic use > J01 - Antibacterials for systemic use > J01C - Beta-lactam antibacterials, penicillins > J01CA - Penicillins with extended spectrum D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D047090 - beta-Lactams D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D010406 - Penicillins D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D007769 - Lactams C254 - Anti-Infective Agent > C258 - Antibiotic > C260 - Beta-Lactam Antibiotic
Piperacillin Sodium
C23H26N5NaO7S (539.1450566000001)
D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D047090 - beta-Lactams D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D010406 - Penicillins D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D007769 - Lactams C254 - Anti-Infective Agent > C258 - Antibiotic > C260 - Beta-Lactam Antibiotic